These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1009527)

  • 1. PHASE I clinical trial of an oral solution of VP-16-213.
    Nissen NI; Dombernowsky P; Hansen HH; Larsen V
    Cancer Treat Rep; 1976 Jul; 60(7):943-5. PubMed ID: 1009527
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral VP-16-213 in transitional cell carcinoma of the bladder: a phase II study.
    Panduro J; Hansen M; Hansen HH
    Cancer Treat Rep; 1981; 65(7-8):703-4. PubMed ID: 7248987
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II clinical trial of VP-16-213 in ovarian cancer.
    Maskens AP; Armand JP; Lacave AJ; De Jager RL; Hansen HH; Wolff JP
    Cancer Treat Rep; 1981; 65(3-4):329-30. PubMed ID: 7016320
    [No Abstract]   [Full Text] [Related]  

  • 4. [A phase II clinical trial of oral VP 16-213 in advanced non-Hodgkin's lymphoma].
    Nakada H; Ogawa M; Ingaki J; Horikoshi N; Inoue K; Usui N; Adachi K; Tada A; Yamazaki H; Mukaiyama T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1644-8. PubMed ID: 6476837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Etoposide: VP-16].
    Dicato M
    Bull Soc Sci Med Grand Duche Luxemb; 1982; 119(2):15-8. PubMed ID: 7160031
    [No Abstract]   [Full Text] [Related]  

  • 6. Response rate and toxicity of etoposide (VP-16) in squamous carcinoma of the lung: report from the Lung Cancer Treatment Study Group.
    Anderson G; Payne H
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):21-2. PubMed ID: 3883504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VP-16-213 (etoposide) in the management of germinal testis tumors.
    Pizzocaro G
    Prog Clin Biol Res; 1985; 203():391-400. PubMed ID: 2421333
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II evaluation of etoposide in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
    Gockerman JP; Bartolucci AA; Nelson MO; Silberman H; Velez-Garcia E; Stein R
    Cancer Treat Rep; 1986 Jun; 70(6):801-2. PubMed ID: 3524829
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose VP 16-213 (NSC 141540) for the treatment of patients with previously treated acute leukemia.
    Van Echo DA; Wiernik PH; Aisner J
    Cancer Clin Trials; 1980; 3(4):325-8. PubMed ID: 6933027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of etoposide in advanced prostate cancer.
    Trump DL; Loprinzi CL
    Cancer Treat Rep; 1984 Sep; 68(9):1195-6. PubMed ID: 6478456
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of etoposide in adenocarcinomas of the upper gastrointestinal tract.
    Kelsen DP; Magill GB; Cheng E; Dukeman M; Sordillo P; Heelan R; Yagoda A
    Cancer Treat Rep; 1983 May; 67(5):509-10. PubMed ID: 6850667
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II trial of VP-16-213 in non-small-cell lung cancer.
    Itri LM; Gralla RJ; Chapman RA; Kelsen DP; Casper ES; Golbey RB
    Am J Clin Oncol; 1982 Feb; 5(1):45-7. PubMed ID: 7081137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group].
    Suzuki K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2772-9. PubMed ID: 3753024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A phase II trial of etoposide (VP-16) administered intravenously in the treatment of malignant lymphoma and acute leukemia].
    Moriyama Y; Shibata A; Maekawa I; Yoshida Y; Miura A; Wakui A; Kariyone S; Maekawa T; Miura Y; Abe T
    Rinsho Ketsueki; 1985 Nov; 26(11):1774-84. PubMed ID: 3835288
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II study of etoposide for carcinoma of the prostate.
    Walther PJ; Williams SD; Troner M; Greco FA; Birch R; Einhorn LH
    Cancer Treat Rep; 1986 Jun; 70(6):771-2. PubMed ID: 3524825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of etoposide in the management of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
    Slayton RE; Blessing JA; Delgado G
    Cancer Treat Rep; 1982 Aug; 66(8):1669-71. PubMed ID: 7105059
    [No Abstract]   [Full Text] [Related]  

  • 17. Multicenter Phase II trial of etoposide in refractory small cell lung cancer.
    Issell BF; Einhorn LH; Comis RL; Lawson RD; Baker LH; Harvey HA; Lanzotti VA; Wampler GL; Daniels JR; Anderson PN
    Cancer Treat Rep; 1985 Jan; 69(1):127-8. PubMed ID: 2981617
    [No Abstract]   [Full Text] [Related]  

  • 18. [A phase II study of oral VP-16 in primary lung cancer].
    Matsui Y; Ohshima S; Kado M; Nakayama M; Shimokata K; Sakai S; Ito F; Chikata E; Hara K; Kanda T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1801-7. PubMed ID: 2994576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospects of new chemotherapies].
    Sculier JP; Klastersky J
    Rev Med Brux; 1982 Oct; 3(8):519-27. PubMed ID: 6897459
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I study of VP-16-213 (Etoposide) administered as a continuous 5-day infusion.
    Lokich J; Corkery J
    Cancer Treat Rep; 1981; 65(9-10):887-9. PubMed ID: 7273024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.